Trial Profile
Study of effects of everolimus on emotional and behavioral symptoms and refractory epilepsy in a group of patients with tuberous sclerosis complex
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Apr 2018
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Tuberous sclerosis
- Focus Adverse reactions
- 16 Apr 2018 New trial record